Vertex Pharmaceuticals (NASDAQ:VRTX)

dollar

These Top Stocks Are Cheap After Huge Market Sell-Off

In just a matter of days, the S&P 500 managed to produce a sell-off of more than 6%. The equity strategy team at Jefferies concede that the recent correction in ...
Read Full Story »
research

Catalysts That Could Push Top Biotech Stocks Even Higher

Despite the hard sell-off in the top biotech names last week, most Wall Street firms remain very positive on the leading stocks. The best thing about the carnage inflicted last ...
Read Full Story »
Biotechnology word cloud

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large cap biotech stocks are poised to beat earnings estimates across ...
Read Full Story »
Pills

UBS Has Nine Biotech Buyout and Merger Candidates

After three years of solid outperformance, most firms on Wall Street that we cover remain very positive on biotechnology as a whole. The analysts at UBS are not only bullish ...
Read Full Story »
JPMorgan_logo

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Biotechnology was an incredible performer in 2013, outperforming the S&P 500 by a stunning 36%. The analysts at J.P. Morgan think that the huge outperformance may lessen but can stay ...
Read Full Story »
yoga

Ten Top Growth Stock Ideas for 2014 From Baird

Many of the top Wall Street firms released their top 2014 ideas in the month of December. This is the first full trading week of 2014, and many firms are ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

Stocks are effectively at all-time highs, and this is the first full week of trading for 2014. Wall Street firms are making their annual outlook reports and calling on the ...
Read Full Story »
2014 in the box

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

All of the major firms on Wall Street we cover have prognostications and stock picks for 2014. The Cowen biotechnology team has a list of top 10 surprises that are ...
Read Full Story »
health care

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%. Its trading volume of almost 9.2 million shares was almost ...
Read Full Story »
biotech

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Even though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Microsoft, Target, Zynga and More

Now that stocks have pulled back and interest rates have risen, investors are looking for more guidance on which stocks they should still buy and which stocks they should sell ...
Read Full Story »
biotech

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

Biotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have ...
Read Full Story »
biotech

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

On Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company ...
Read Full Story »
biotech

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

The higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Comerica, Maxim and SeaWorld

Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell ...
Read Full Story »